CLEVIPREX recall (Chiesi USA, Inc.)
DrugClass IIOngoing
Summary: Chiesi USA, Inc. is recalling CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary, NC 27518, by Fresenius Kabi, Graz, Austria, NDC 10122-611-10.. Reason: Lack of Assurance of Sterility.
What is being recalled
CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary, NC 27518, by Fresenius Kabi, Graz, Austria, NDC 10122-611-10.
Why
Lack of Assurance of Sterility
How serious is it
Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.
Where it was sold
Nationwide within the United States
How to tell if yours is affected
Lot #: 1239521, 1237454, Exp. Date 10/2027
What to do
Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.
Recall facts
| Recall number | D-0689-2026 |
| Category | Drug |
| Agency | U.S. Food and Drug Administration (FDA) |
| Severity | Class II |
| Status | Ongoing |
| Recall started | July 6, 2026 |
| Reported | July 22, 2026 |
| Company | Chiesi USA, Inc. |
| Company location | Cary, NC, United States |
| Initiated by | Voluntary: Firm initiated |
| Quantity | 44280 vials |
More recalls from Chiesi USA, Inc. · all drug recalls · recalls from July 2026